Nanox to Report First Quarter 2025 Financial Results on May 22, 2025
Nanox (NASDAQ: NNOX), a medical imaging technology company, has scheduled its first quarter 2025 financial results announcement for May 22, 2025, before the market opens. The company will host a conference call and webcast at 8:30 a.m. ET on the same day, featuring CEO and Acting Chairman Erez Meltzer and CFO Ran Daniel, who will discuss the quarterly results and provide a business update.
Nanox (NASDAQ: NNOX), un'azienda specializzata in tecnologia per l'imaging medico, ha programmato l'annuncio dei risultati finanziari del primo trimestre 2025 per il 22 maggio 2025, prima dell'apertura del mercato. La società terrà una conference call e una webcast alle 8:30 a.m. ET dello stesso giorno, con la partecipazione del CEO e Presidente ad interim Erez Meltzer e del CFO Ran Daniel, che discuteranno i risultati trimestrali e forniranno un aggiornamento sull'andamento aziendale.
Nanox (NASDAQ: NNOX), una empresa de tecnología en imágenes médicas, ha programado el anuncio de sus resultados financieros del primer trimestre de 2025 para el 22 de mayo de 2025, antes de la apertura del mercado. La compañía realizará una llamada conferencia y una transmisión en vivo a las 8:30 a.m. ET del mismo día, con la participación del CEO y Presidente interino Erez Meltzer y del CFO Ran Daniel, quienes discutirán los resultados trimestrales y ofrecerán una actualización del negocio.
Nanox (NASDAQ: NNOX)는 의료 영상 기술 회사로, 2025년 1분기 재무 결과 발표를 2025년 5월 22일 시장 개장 전에 예정했습니다. 회사는 같은 날 동부 시간 오전 8시 30분에 CEO 겸 임시 회장 에레즈 멜처(Erez Meltzer)와 CFO 랜 다니엘(Ran Daniel)이 참석하는 컨퍼런스 콜과 웹캐스트를 진행하며, 분기 실적과 사업 현황을 논의할 예정입니다.
Nanox (NASDAQ : NNOX), une entreprise spécialisée dans la technologie d'imagerie médicale, a programmé l'annonce de ses résultats financiers du premier trimestre 2025 pour le 22 mai 2025, avant l'ouverture du marché. La société organisera une conférence téléphonique et une webdiffusion à 8h30 ET le même jour, avec la participation du PDG et président par intérim Erez Meltzer ainsi que du directeur financier Ran Daniel, qui discuteront des résultats trimestriels et fourniront une mise à jour sur l'activité.
Nanox (NASDAQ: NNOX), ein Unternehmen für medizinische Bildgebungstechnologie, hat die Bekanntgabe der Finanzergebnisse für das erste Quartal 2025 für den 22. Mai 2025 vor Börsenbeginn geplant. Das Unternehmen wird am selben Tag um 8:30 Uhr ET eine Telefonkonferenz und Webcast veranstalten, bei der CEO und amtierender Vorsitzender Erez Meltzer sowie CFO Ran Daniel die Quartalsergebnisse erläutern und ein Geschäftsupdate geben werden.
- None.
- None.
PETACH TIKVA, Israel, May 08, 2025 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD ("Nanox" or the "Company", Nasdaq: NNOX), an innovative medical imaging technology company, today announced that it will report its financial results for the quarter ended March 31, 2025, before market open on Thursday, May 22, 2025. Erez Meltzer, Chief Executive Officer and Acting Chairman, and Ran Daniel, Chief Financial Officer, will host a conference call to review these results and provide a business update beginning at 8:30 a.m. ET.
Interested parties may register for the conference call using the following link: Nanox Q1 2025 Earnings Call Registration. The live webcast of the conference call may be accessed by using the following link: Nanox Q1 2025 Earnings Webcast. The link will also be posted in the Investor Relations section of the Nanox website at Events and Presentations.
About Nanox
Nanox (NASDAQ: NNOX) is focused on driving the world’s transition to preventive health care by bringing a full solution of affordable medical imaging technologies based on advanced AI and proprietary digital X-ray source.
Nanox's vision encompasses expanding the reach of Nanox technology both within and beyond hospital settings, providing a seamless end-to-end solution from scan to diagnosis, leveraging AI for more accurate diagnostics and maintaining a clinically driven approach. The Nanox ecosystem includes Nanox.ARC – a multi-source digital tomosynthesis system that is cost-effective and user-friendly; Nanox.AI LTD, a subsidiary of Nanox Imaging, with an AI-based suite of algorithms that augment the readings of routine CT imaging to highlight early signs often related to chronic diseases; Nanox.CLOUD – a cloud-based software platform that manages data collected by Nanox devices, and provides users with tools for in-depth imaging analysis; Nanox.MARKETPLACE – a proprietary decentralized marketplace through Nanox’s subsidiary, USARAD Holdings Inc., that provides remote access to radiology and cardiology experts, and a comprehensive teleradiology services platform. By improving early detection and treatment, Nanox aims to enhance better health outcomes worldwide. For more information, please visit www.nanox.vision.
Contacts
Investor Contact
Mike Cavanaugh
ICR Healthcare
mike.cavanaugh@icrhealthcare.com
Media Contact
ICR Healthcare
NanoxPR@icrinc.com
FAQ
When will Nanox (NNOX) report its Q1 2025 earnings?
What time is the Nanox (NNOX) Q1 2025 earnings call?
Who will host the Nanox (NNOX) Q1 2025 earnings call?
How can I access the Nanox (NNOX) Q1 2025 earnings call?
